NAVARRO CANCER TEST
2x monthly - included
EFREN NAVARRO, M.D., University of Santo Tomas Faculty of Medicine and Surgery, Philippines. Performed his residency at Mercy Hospital Medical Center in Chicago, and in 1994 became a Hematopathology Fellow at the University of Illinois.
In 1996, he returned to the Philippines to continue the work of his father, Manuel Navarro, M.D., developer of the Beta HCG (Human Chorionic Gonadotropin) Immunoassay Test for Cancer. The Navarro's say the urine test detects the presence of the substance "HCG," indicating the presence of cancer cells before signs or symptoms develop.
The test is based on a theory that cancer is related to misplaced trophoblastic cells that secrete HCG. As a consequence, Dr. Navarro says that a measure of the amount of HCG found in blood or urine also measures the degree of malignancy. The higher the number, the greater the malignancy. He also says that cancer patients can use the test to measure the effectiveness of any therapy.For the sample, put a cup of the first urine after midnight in a sterilized glass jar. The results will be available by 10 a.m. the next day. Men should abstain form sex 24 hours prior to the urine sample, women for 12 days, and for pre-menopausal women, the sample should be taken at least seven days after the menstrual blood flow stops.
Published papers on the HCG Immuno Assay Test include: A Screening Test for Malignancy, Journal of the Philippine Medical Association, Manuel Navarro, M.D., 1965. Immunological Test for Cancer, Santo Tomas Journal of Medicine, Vol. XXI, No. 6-Nov./Dec. 1966, Manuel Navarro, M.D. HCG As A Specific Marker in Malignancy, Book of Abstracts of the 4th International Symposium for the Prevention and Detection of Cancer, London, England, Manuel Navarro, M.D., July 26-31, 1980. Studies on the Sensitiveness of Radio immunoassay (RIA), Enzyme Immunoassay (EIA) and Urinary HCG Immunoassay in the Detection of Beta HCG, Journal of Nutrition, Growth and Cancer, Manuel Navarro, M.D. Ectopic Production of Human Chorionic Gonadotropin (hCG) by Neoplasm's: The Value of Measurements of Immuno reactive hCG in the Urine as a Screening Procedure, University of Athens School of Medicine, Greece, P.D. Papapetrou, M.D., May 23, 1979. Reprinted by the American Cancer Society in Cancer 1980. HCG-Immunoassay for the Early Detection of Cancer, Acta Manilana, Ser A 20(30) pp. 12-21, Efren Navarro, M.D., 1981.